France's Agence régionale de santé Nouvelle-Aquitaine (ARS) recenlty confirmed a patient had been infected with West Nile virus (WNV) in New Aquitaine.
This WNV patient is from Bordeaux, and ARS is investigating four suspected cases.
Previously, human infections with WNV were reported in France's Mediterranean (PACA and Occitanie regions).
"Their state of health does not inspire concern, and they are on the way to recovery," said the ARS statement on August 1, 2023.
West Nile Virus Confirmed in Wine Country
New HIV-related Genetic Variant Discovered
A significant breakthrough in the clinical understanding of the human immunodeficiency virus (HIV) was announced today that may lead to new treatment and prevention strategies, such as vaccines.
This is the first new genetic variant discovered in nearly 30 years of HIV research, says the Public Health Agency of Canada.
Early-Stage Cancer Diagnoses Decreased During First Year of COVID-19
Pattern most prominent for Hispanics, Asian American and Pacific Islanders, uninsured, those in most socioeconomically deprived areas
Syphilis Rates Significantly Spike in Certain States
The leadership of the U.S. Health Resources and Services Administration (HRSA) recently announced increasing syphilis rates have been confirmed within American Indian / Alaskan Native (AI/AN) communities.
In partnership with the Indian Health Service (IHS), HRSA highlighted escalating syphilis rates within Alaska, Arizona, Montana, Nebraska, New Mexico, Oregon, and South Dakota on July 6, 2023.
As an example, syphilis rates in Alaska have risen annually since 2018, reported the state Health Department on August 1, 2023.
$704 Million Awarded for Advanced Ebola Treatment
Emergent BioSolutions Inc. recently announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), valued at up to a maximum of $704 million.
This contract is for advanced development, manufacturing scale-up, and procurement of Ebanga™, a U.S. FDA-licensed Ebola virus disease (EVD) treatment.
Maternity Care ‘Deserts’ Common Throughout America, Report Shows
More than 5.6 million women in the U.S. and Puerto Rico live in counties with little or no access to maternity care
RSV Vaccinations Offered at Pharmacies
A leading pharmacy chain today announced it is offering respiratory syncytial virus (RSV) vaccination and testing appointments through about 9,000 locations in the U.S.
Walgreens Co. confirmed on August 1, 2023, eligible individuals ages 60 years and older can receive one of the U.S. FDA-approved RSV vaccines following a clinical discussion with a healthcare provider.
RSV vaccination appointments will be available at most locations during nights, weekends, and walk-ins.
RSV Testing and Vaccinations Offered at Pharmacies
A leading pharmacy chain today announced it is offering respiratory syncytial virus (RSV) vaccination and testing appointments through about 9,000 locations in the U.S.
Walgreens Co. confirmed on August 1, 2023, eligible individuals ages 60 years and older can receive one of the U.S. FDA-approved RSV vaccines following a clinical discussion with a healthcare provider.
RSV vaccination appointments will be available at most locations during nights, weekends, and walk-ins.
Oral Probenecid Cuts Time to Viral Clearance in COVID-19
Median time to viral clearance was significantly shorter for 500, 1,000 mg probenecid versus placebo
Biotech Company Settles With Family of Henrietta Lacks, Whose Cells Revolutionized Medicine
Henrietta Lacks’ cells were taken without her knowledge while she was a cancer patient more than 70 years ago and were the first to be successfully cloned